2Stevens DA,Kan VL,Judson MA,et al.Practice guidelines for diseases caused by Aspergillus.Infectious Diseases Society of America[J].Clin Infect Dis,2000,30:696-709. 被引量：1
3Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J].Clin Infect Dis,2002,34:7-14. 被引量：1
4Denning DW,Kibbler CC,Barnes RA,et al.British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections[J].Lancet Infect Dis,2003,3:230-240. 被引量：1
5Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis[J].Clin Infect Dis,2004,38:161-189. 被引量：1
6Slavin MA,Szer J,Grigg AP,et al.Guidelines for the use of antifungal agents in the treatment of invasive Candida and mould infections[J].Intern Med J,2004,34:192-200. 被引量：1
7Saag MS,Graybill RJ,Larsen RA,et al.Practice guidelines for the management of cryptococcal disease.Infectious Diseases Society of America[J].Clin Infect Dis,2000,30:710-718. 被引量：1
